By 2004, reported global estimates of breast cancer deaths exceeded 500,000 victims. The vast majority were women. This type of cancer most commonly originates in the milk ducts from a corrupted breast cell(s), that if left unchecked, can invade surrounding breast tissue with devastating results.
Rated 1.5 / 5 (How Ratings Work)
Possibility of efficacy for cannabis in treatment of cancer (breast) .
Based on 24 Studies from 1998 - 2016
Study Name, Description & Year
Rating
Simultaneous Activation Of Induced Heterodimerization Between CXCR4 Chemokine Receptor And Cannabinoid Receptor 2 (CB2) Reveal A Mechanism For Regulation Of Tumor Progression
Laboratory Study — 2016
Cannabidiolic Acid-mediated Selective Down-regulation Of C-fos In Highly Aggressive Breast Cancer MDA-MB-231 Cells: Possible Involvement Of Its Down-regulation In The Abrogation Of Aggressiveness
Laboratory Study — 2016
Phyto-, Endo- And Synthetic Cannabinoids: Promising Chemotherapeutic Agents In The Treatment Of Breast And Prostate Carcinomas
Review — 2016
Modulation Of The Tumor Microenvironment And Inhibition Of EGF/EGFR Pathway; Novel Anti-tumor Mechanisms Of Cannabidiol In Breast Cancer
Animal study (mice) — 2015
Modulation Of The Tumor Microenvironment And Inhibition Of EGF/EGFR Pathway; Novel Anti-tumor Mechanisms Of Cannabidiol In Breast Cancer
Laboratory Study — 2015
Selective, Nontoxic CB(2) Cannabinoid O-quinone With In Vivo Activity Against Triple-negative Breast Cancer.
Laboratory and animal tests (mice) — 2015
A Selective, Non-toxic CB2 Cannabinoid O-quinone With In Vivo Activity Against Triple Negative Breast Cancer.
Laboratory Study — 2015
Modulation Of The Tumor Microenvironment And Inhibition Of EGF/EGFR Pathway: Novel Anti-tumor Mechanisms Of Cannabidiol In Breast Cancer
Laboratory Study — 2015
Targeting Multiple Cannabinoid Anti-tumour Pathways With A Resorcinol Derivative Leads To Inhibition Of Advanced Stages Of Breast Cancer
Laboratory Study — 2014
Cannabidiol Inhibits Lung Cancer Cell Invasion And Metastasis Via Intercellular Adhesion Molecule-1
Laboratory Study — 2012
Cannabidiol As Potential Anticancer Drug
Review — 2012
B-Caryophyllene Oxide Inhibits Growth And Induces Apoptosis Through The Suppression Of PI3K/AKT/mTOR/S6K1 Pathways And ROS-mediated MAPKs Activation.
Laboratory Study — 2011
Pathways Mediating The Effects Of Cannabidiol On The Reduction Of Breast Cancer Cell Proliferation, Invasion, And Metastasis
Animal study (mice) — 2011
Cannabinoids Reduce ErbB2-driven Breast Cancer Progression Through Akt Inhibition
Animal study (mice) — 2010
JunD Is Involved In The Antiproliferative Effect Of Δ9-tetrahydrocannabinol On Human Breast Cancer Cells
Laboratory — 2008
JunD Is Involved In The Antiproliferative Effect Of Δ9-tetrahydrocannabinol On Human Breast Cancer Cells
Animal study (mice) — 2008
Cannabidiol As A Novel Inhibitor Of Id-1 Gene Expression In Aggressive Breast Cancer Cells
Laboratory — 2007
Cannabidiol As A Novel Inhibitor Of Id-1 Gene Expression In Aggressive Breast Cancer Cells
Animal study (mice) — 2007
Potentiating Effect Of Beta-caryophyllene On Anticancer Activity Of Alpha-humulene, Isocaryophyllene And Paclitaxel
Laboratory Study — 2007
Δ9-Tetrahydrocannabinol Inhibits Cell Cycle Progression In Human Breast Cancer Cells Through Cdc2 Regulation
Laboratory — 2006
CB(2) Cannabinoid Receptor Activation Is Cardioprotective In A Mouse Model Of Ischemia/reperfusion
Animal study (mice) — 2006
The Endogenous Cannabinoid Anandamide Inhibits Human Breast Cancer Cell Proliferation
Laboratory — 1998